 |
|
Sensor biochips could aid in cancer diagnosis and treatment
October 22, 2009It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs. With the help of microchips, they can establish in the laboratory whether a patient's tumor cells will react to a given drug. This chip could help in future with the rapid identification of the most effective medication for the individual patient.
Cancer is the second most common cause of death in the Western world. According to the German Cancer Research Center in Heidelberg, approximately 450,000 people develop cancer every year in Germany. Although the doctors who treat cancer have numerous cancer drugs at their disposal today, the treatment must be precisely tailored to the patient and the type of cancer in question to be as effective as possible. If it takes a second or third try to find a drug that works, the patient loses valuable time in which the tumor can continue to grow.
In the future, miniature laboratories could provide the fast help required here. A lab-on-a-chip is a device -- made of glass, for example -- that is just a few millimeters across and has bioelectronic sensors that monitor the vitality of living cells. The chips sit in small wells, known as microtiter plates, and are covered with a patient's tumor cells. A robot changes the culture fluid in each well containing a chip at intervals of just a few minutes. The microsensors on the chip record, among other things, changes in the acid content of the medium and the cells' oxygen consumption; photographs of the process are also taken by a microscope fitted underneath the microtiter plate. All of the data merge in a computer that is connected to the system, and which provides an overview of the metabolic activity of the tumor cells and their vitality.
The robots and microtiter plates are kept in a chamber which, through precisely regulated temperature and humidity, provides an environment similar to that of the human body, and which also protects the tumor cells against external influences that can falsify the test results.
After the tumor cells have been able to divide undisturbed for a few hours, the robot applies an anti-cancer substance. If their metabolic activity declines over the next day or two, the active substance was able to kill the tumor cells and the drug is effective. Using the microchips, twenty-four active substances or combinations of active substances can be tested simultaneously in this way.
The gain in time for the patient is not the only positive factor here. Dr. Helmut Grothe, a scientist from the Heinz Nixdorf Chair at the TUM, explains: "Treatment with an ineffective cancer drug sometimes leads to the development of resistance to other drugs in the patient." Such resistance on the part of the tumor cells can also be identified at an early stage with the help of the sensor chip.
Another advantage of the system is its automation. The robot works faster and more accurately than any human could. Hence, the test results can be obtained quickly, which, in turn, saves on costs. Furthermore, the possibility of testing tumor cells with several active substances simultaneously facilitates the search for effective substances for individually tailored cancer treatment. Pharmaceutical companies may also be able to use the sensor chip in the development of new drugs in future.
As part of another research project, the scientists at the Heinz Nixdorf Chair are also developing a sensor chip that is intended to control tumor growth. The chip, which would be implanted once in the vicinity of the tumor, could release cancer drugs or pain medication only when the tumor grows. The release of the active substances would be controlled by electrical impulses. This sensor system could be used in the treatment of inoperable tumors, for example pancreatic tumors.
In the past, microchips have also been developed at the TUM's Heinz Nixdorf Chair for use in other research fields. For example, one such system is used in the analysis of the water quality of streams and rivers. In this case, a small pump removes samples at regular intervals from the water body and channels it via a pipe to a sensor chip on which algae have been planted. As algae are highly sensitive to toxic substances, they are particularly suitable for water analysis and react to the minutest impurities: their metabolic activity, which is measured on the basis of their oxygen production, declines in less than one minute in the presence of toxins. The data recorded by this sensor system are transmitted via mobile telephone to a computer that raises the alarm. The TUM research team won the E.ON Environmental Award, presented by the Bavarian energy company of the same name, for this system in 2008.
Technische Universitaet Muenchen
The robots and microtiter plates are kept in a chamber which, through precisely regulated temperature and humidity, provides an environment similar to that of the human body, and which also protects the tumor cells against external influences that can falsify the test results.
After the tumor cells have been able to divide undisturbed for a few hours, the robot applies an anti-cancer substance. If their metabolic activity declines over the next day or two, the active substance was able to kill the tumor cells and the drug is effective. Using the microchips, twenty-four active substances or combinations of active substances can be tested simultaneously in this way.
The gain in time for the patient is not the only positive factor here. Dr. Helmut Grothe, a scientist from the Heinz Nixdorf Chair at the TUM, explains: "Treatment with an ineffective cancer drug sometimes leads to the development of resistance to other drugs in the patient." Such resistance on the part of the tumor cells can also be identified at an early stage with the help of the sensor chip.
Another advantage of the system is its automation. The robot works faster and more accurately than any human could. Hence, the test results can be obtained quickly, which, in turn, saves on costs. Furthermore, the possibility of testing tumor cells with several active substances simultaneously facilitates the search for effective substances for individually tailored cancer treatment. Pharmaceutical companies may also be able to use the sensor chip in the development of new drugs in future.
As part of another research project, the scientists at the Heinz Nixdorf Chair are also developing a sensor chip that is intended to control tumor growth. The chip, which would be implanted once in the vicinity of the tumor, could release cancer drugs or pain medication only when the tumor grows. The release of the active substances would be controlled by electrical impulses. This sensor system could be used in the treatment of inoperable tumors, for example pancreatic tumors.
In the past, microchips have also been developed at the TUM's Heinz Nixdorf Chair for use in other research fields. For example, one such system is used in the analysis of the water quality of streams and rivers. In this case, a small pump removes samples at regular intervals from the water body and channels it via a pipe to a sensor chip on which algae have been planted. As algae are highly sensitive to toxic substances, they are particularly suitable for water analysis and react to the minutest impurities: their metabolic activity, which is measured on the basis of their oxygen production, declines in less than one minute in the presence of toxins. The data recorded by this sensor system are transmitted via mobile telephone to a computer that raises the alarm. The TUM research team won the E.ON Environmental Award, presented by the Bavarian energy company of the same name, for this system in 2008.
Technische Universitaet Muenchen
Cancer Diagnosis Current Events and Cancer Diagnosis News RSSFor young boys with cancer, testicular tissue banking may be option to preserve fertility
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.
Intervals between lung cancer diagnosis and treatment displays a health care disparity
Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies.
Brain tumors in childhood leave a lasting mark on cognition, life status
Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of these tumors -- the most common solid malignancies in childhood -- shows that survivors have ongoing cognitive problems.
URI research couple's method targets cancerous tumors
Two University of Rhode Island associate professors, biophysicists Yana Reshetnyak and Oleg Andreev, have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects.
UB Study Explores How Women Make Decisions About Breast Cancer Surgery
For women just diagnosed with breast cancer, one of the important decisions confronting them is whether to have a lumpectomy or mastectomy. A diagnosis of breast cancer will affect one in every eight women in the United States.
UNC expert: Better decision support tools needed for prostate cancer screening choice
Although screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain.
More women choosing to remove healthy breast after cancer diagnosis
A new study of New York State data finds that the number of women opting for surgery to remove the healthy breast after a cancer diagnosis in one breast is rising, despite a lack of evidence that the surgery can improve survival.
Protein complex key in avoiding DNA repair mistakes, cancer
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Physician trust, early screening reduces disparities for prostate cancer
Men who have a regular, ongoing relationship with a health care provider are more likely to receive prostate cancer screening and less likely to be diagnosed with advanced prostate cancer, regardless of their race, according to a University of North Carolina study published in the current issue of the journal Cancer.
2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
More Cancer Diagnosis Current Events and Cancer Diagnosis News Articles
 |
Cancer Diagnosis: What to Do Next by W. John Diamond (Author) The complete guide to early detection and prevention of cancer and with proven safe and nontoxice treatments. |
 |
Breast Cancer? But Doctor....I hate pink by Ann Silberman With an humor and intelligence, Ann Silberman, breast-cancer "ass-kicker," describes her life since diagnosis. She found her lump in May 2009 and was diagnosed in early September. She is sharing her journey through surgeries and chemo as they happen. A must-read for anybody who either has cancer or has a family member with this disease. Ann writes with wit and energy in her blog: Breast Cancer? But Doctor ... I hate pink.Kindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day. |
 |
Prostate Cancer: Prevention, Diagnosis, and Treatment Prostate cancer is the most commonly diagnosed cancer in men in the United States. Virtually every man over 40 has cancerous growths in his prostate, although most will not die of the disease. This program focuses on what is known about preventing prostate cancer, current diagnostic techniques, and the variety of treatments available. James D. Brooks, MD, is Assistant Professor of Urology at the Stanford University School of Medicine. Dr. Brooks focuses exclusively on the treatment of prostate cancer. He is an acknowledged expert in the technique of nerve-sparing radical retropubic prostatectomy and in the surgical anatomy of the pelvis, and has carried out pioneering research on the genetic changes occurring in urological cancers. He has also published extensively on scientific and... |
 |
EARLY CANCER CONTROL DIAGNOSIS TREATMENT AMERICAN US USA SMALL VINTAGE POSTER REPRO by WONDERFULITEMS THIS IS A BEAUTIFUL / GREAT QUALITY REPRODUCTION VINTAGE POSTER !!! THE POSTERS ARE PRINTED ON HEAVYWEIGHT PROFESSIONAL MATTE PAPER USING **GICLEE** TECHNIQUE. THE QUALITY OF THE IMAGES IS JUST AMAZING!!! 100% SATISFACTION GUARANTEE!!! IF YOU ARE NOT SATISFIED JUST RETURN THE POSTER, NO QUESTIONS ASKED!!! IMAGE SIZE IS 12" X 16" INCHES - PAPER SIZE IS 15" X 18" INCHES. THIS POSTER WILL MAKE A FANTASTIC ADDITION TO THE HOME DÉCOR!!! ***HIGH QUALITY POSTER FOR DISCERNING CLIENTES!!!!!*** |
 |
Cancer Man Starring: Charles Baker, Frederic Doss, Matt L. Jones, Aaron Paul, Steven Michael Quezada Also With: Sony Home Entertainment (Producer) |
 |
Initial Discovery and Diagnosis of Breast Cancer - Tape 1 This video tells the stories of how several women learned about their breast cancer and started their journeys to become survivors. You will see that no two people react exactly the same way to breast cancer; every woman's response is different but valid. The makers of this video hope it will help you feel less fearful and alone as you travel on your own road to recovery. |
 |
Diagnosis Cancer Stuart Turner (Primary Contributor) |
 |
Cancer Pain: Assessment, Diagnosis, And Management by Lippincott Williams & Wilkins Cancer Pain: Assessment, Diagnosis, and Management : Cancer Pain: Assessment, Diagnosis, and Management Pub Date: January 2010 Product Type: Print Author/s: Dermot R Fitzgibbon MB, BCh; John D Loeser MD This book provides, in a single cohesive source, all the information a health care professional needs to diagnose and select appropriate treatments for the patient with pain associated with cancer. Cancer Pain: Assessment, Diagnosis, and Management is clinically oriented and comprehensively addresses all the issues surrounding modern cancer pain management. The authors provide detailed information on common but difficult to treat cancer pain scenarios. Coverage includes state-of-the-art information on treatment options and discussions of the impact of radiation,... |
 |
Cancer Research / Testing Cells Directed By: Rex Barnett |
 |
Prostate and Cancer: A Family Guide to Diagnosis, Treatment, and Survival by Sheldon Marks MD (Author) Prostate cancer is one of the most common cancers affecting American men, with over 186,000 new cases diagnosed in the United States annually; 1 in 6 men will be diagnosed with prostate cancer during his lifetime. Renowned prostate cancer specialist Sheldon Marks offers the definitive guide for men concerned about or diagnosed with prostate cancer, and for their families. Since the third edition (2003), there have been significant changes in treatment and resources. Working with Dr. Judd Moul, the Chairman of Urology at Duke and one of the world’s top experts on prostate cancer, Marks provides the most up-to- date information on diagnosis, treatment, and common questions. |
| © 2009 BrightSurf.com |